Home > Browse by Creator/Editor where creator/editor is "Huestis, Marilyn A"

up arrow imageUp a level
Export as
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 5.

Article

Wade, Natasha E and Sullivan, Ryan M and Tapert, Susan F and Pelham, William E and Huestis, Marilyn A and Lisdahl, Krista M and Haist, Frank (2023) Concordance between substance use self-report and hair analysis in community-based adolescents. The American Journal of Drug and Alcohol Abuse , 49 , (1) , pp. 76-84.

Marcotte, Thomas D and Umlauf, Anya and Grelotti, David J and Sones, Emily G and Sobolesky, Philip M and Smith, Breland E and Hoffman, Melissa A and Hubbard, Jacqueline A and Severson, Joan and Huestis, Marilyn A and Grant, Igor and Fitzgerald, Robert L (2022) Driving performance and cannabis users' perception of safety: a randomized clinical trial. JAMA Psychiatry , 79 , (3) , pp. 201-209.

Hudzik, Thomas J and Huestis, Marilyn A and Rossi, Sabina Strano and Schumacher, Yorck-Olaf and Harcourt, Peter and Budgett, Richard and Stuart, Mark and Tettey, Justice and Mazzoni, Irene and Rabin, Olivier and Danion, Anne and Culler, Michael and Handelsman, David and Thevis, Mario and Kinahan, Audrey (2023) Editorial. Cannabis and sport: a World Anti-Doping perspective. Addiction , 118 , (11) , pp. 2040-2042.

Di Trana, Annagiulia and Berardinelli, Diletta and Montanari, Eva and Berretta, Paolo and Basile, Giuseppe and Huestis, Marilyn A and Busardò, Francesco Paolo (2022) Molecular insights and clinical outcomes of drugs of abuse adulteration: new trends and new psychoactive substances. International Journal of Molecular Sciences , 23 , (23) .

Mohr, Amanda L A and Logan, Barry K and Fogarty, Melissa F and Krotulski, Alex J and Papsun, Donna M and Kacinko, Sherri L and Huestis, Marilyn A and Ropero-Miller, Jeri D (2022) Reports of adverse events associated with use of novel psychoactive substances, 2017–2020: a review. Journal of Analytical Toxicology , 46 , (6) , e116-e185.

This list was generated on Sat Apr 13 04:16:20 2024 IST.